BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1330864)

  • 41. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA.
    Leibovitch L; George J; Levi Y; Bakimer R; Shoenfeld Y
    Immunol Lett; 1995 Dec; 48(2):129-32. PubMed ID: 8719111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antilactoferrin antibodies in autoimmune liver disease.
    Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
    Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Autoantibodies of central importance for diagnosis].
    Dahle C
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1379-81. PubMed ID: 20645612
    [No Abstract]   [Full Text] [Related]  

  • 44. A dot-immunobinding assay for antimitochondrial antibodies.
    Penner E; Goldenberg H; Meryn S; Gordon J
    Hepatology; 1986; 6(3):381-4. PubMed ID: 3519415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mitochondrial antigens and their antibodies].
    De Groote J
    Acta Gastroenterol Belg; 1991; 54(1):19-26. PubMed ID: 2058346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discrimination between M2 and M4 antimitochondrial antibodies in primary biliary cirrhosis.
    Ghadiminejad I; Baum H
    Biosci Rep; 1986 Dec; 6(12):1049-56. PubMed ID: 3555642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens.
    Flannery GR; Burroughs AK; Butler P; Chelliah J; Hamilton-Miller J; Brumfitt W; Baum H
    Hepatology; 1989 Sep; 10(3):370-4. PubMed ID: 2474482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis.
    Leung PS; Iwayama T; Prindiville T; Chuang DT; Ansari AA; Wynn RM; Dickson R; Coppel R; Gershwin ME
    Hepatology; 1992 Mar; 15(3):367-72. PubMed ID: 1371979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticalmodulin autoantibody in liver diseases: a new antibody against a cytoskeleton-related protein.
    Ikeda Y; Toda G; Hashimoto N; Aotsuka S; Yokohari R; Maruyama T; Oka H
    Hepatology; 1987; 7(2):285-93. PubMed ID: 3557308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders.
    Mason AL; Xu L; Guo L; Munoz S; Jaspan JB; Bryer-Ash M; Cao Y; Sander DM; Shoenfeld Y; Ahmed A; Van de Water J; Gershwin ME; Garry RF
    Lancet; 1998 May; 351(9116):1620-4. PubMed ID: 9620716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticentromere antibody in primary biliary cirrhosis.
    Bernstein RM; Callender ME; Neuberger JM; Hughes GR; Williams R
    Ann Rheum Dis; 1982 Dec; 41(6):612-4. PubMed ID: 7149799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common lupus anti-DNA antibody idiotypes in chronic liver diseases.
    Konikoff F; Isenberg DA; Kooperman O; Kennedy RC; Rauch J; Theodor E; Shoenfeld Y
    Clin Immunol Immunopathol; 1987 May; 43(2):265-72. PubMed ID: 3568459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis.
    Bassendine MF; Fussey SP; Mutimer DJ; James OF; Yeaman SJ
    Semin Liver Dis; 1989 May; 9(2):124-31. PubMed ID: 2471276
    [No Abstract]   [Full Text] [Related]  

  • 54. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.
    Ben-Ari Z; Panagou M; Patch D; Bates S; Osman E; Pasi J; Burroughs A
    J Hepatol; 1997 Mar; 26(3):554-9. PubMed ID: 9075662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets.
    Vento S; O'Brien CJ; McFarlane BM; McFarlane IG; Eddleston AL; Williams R
    Gastroenterology; 1986 Oct; 91(4):810-7. PubMed ID: 2427384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary biliary cirrhosis/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: a case report and review of the literature.
    González LA; Orrego M; Ramírez LA; Vásquez G
    Lupus; 2011 Jan; 20(1):108-11. PubMed ID: 20724352
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.
    Weber P; Brenner J; Stechemesser E; Klein R; Weckenmann U; Klöppel G; Kirchhof M; Fintelmann V; Berg PA
    Hepatology; 1986; 6(4):553-9. PubMed ID: 3089894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoreactivity against biliary tract antigens in primary biliary cirrhosis.
    McFarlane IG
    Mol Aspects Med; 1985; 8(3):249-67. PubMed ID: 3913832
    [No Abstract]   [Full Text] [Related]  

  • 59. [Reynolds syndrome: the combination of scleroderma and primary biliary cirrhosis. Case report].
    Brzezińska-Kolarz B; Undas A; Dyczek A; Musiał J
    Pol Arch Med Wewn; 2001 Mar; 105(3):231-4. PubMed ID: 11680268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimitochondrial antibodies in primary biliary cirrhosis.
    Berg PA; Klein R; Lindenborn-Fotinos J
    J Hepatol; 1986; 2(1):123-31. PubMed ID: 2419388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.